EW · 10-Q · 2026Q2 · Full report
Trade Policy and Tariffs
Edwards Lifesciences Corp · 2026-08-04 · Importance 37 · Surprise 42
Edwards stated that changes to U.S. trade policy include increased tariffs on imports and non-U.S. retaliatory tariffs. The company is assessing potential effects and may pursue supply-chain actions and tariff exemptions or exclusions to mitigate the impact. Management warned that unmitigated tariffs, including related inflation affecting customers, could reduce demand and adversely affect the business, financial condition, and results of operations. Because future U.S. trade policy and tariff rates remain uncertain, Edwards cannot predict the tariffs’ nature or whether mitigation will succeed.
Key facts
- Foreign currency exchange rate fluctuations increased TAVR net sales outside of the United States by $8.4 million for the three months ended June 30, 2026 and by $40.4 million for the six months ended June 30, 2026, primarily due to the strengthening of the Euro. source